|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pisters KM, Evans WK, Azzoli CG, Kris MG,
Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis
PM, et al Cancer Care Ontario; American Society of Clinical
Oncology: Cancer Care Ontario and American Society of Clinical
Oncology adjuvant chemotherapy and adjuvant radiation therapy for
stages I-IIIA resectable non small-cell lung cancer guideline. J
Clin Oncol. 25:5506–5518. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crinò L, Weder W, van Meerbeeck J and
Felip E; ESMO Guidelines Working Group: Early stage and locally
advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 21(Suppl 5): v103–v115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Furuse K, Fukuoka M, Kawahara M, Nishikawa
H, Takada Y, Kudoh S, Katagami N and Ariyoshi Y: Phase III study of
concurrent versus sequential thoracic radiotherapy in combination
with mitomycin, vindesine, and cisplatin in unresectable stage III
non-small-cell lung cancer. J Clin Oncol. 17:2692–2699.
1999.PubMed/NCBI
|
|
7
|
Pfister DG, Johnson DH, Azzoli CG, Sause
W, Smith TJ, Baker S Jr, Olak J, Stover D, Strawn JR, Turrisi AT,
et al American Society of Clinical Oncology: American Society of
Clinical Oncology treatment of unresectable non-small-cell lung
cancer guideline: Update 2003. J Clin Oncol. 22:330–353. 2004.
View Article : Google Scholar
|
|
8
|
Eberhardt W, Pöttgen C and Stuschke M:
Chemoradiation paradigm for the treatment of lung cancer. Nat Clin
Pract Oncol. 3:188–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wardman P: Chemical radiosensitizers for
use in radiotherapy. Clin Oncol (R Coll Radiol). 19:397–417. 2007.
View Article : Google Scholar
|
|
10
|
Kim IA, Bae SS, Fernandes A, Wu J, Muschel
RJ, McKenna WG, Birnbaum MJ and Bernhard EJ: Selective inhibition
of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the
radiosensitivity of human carcinoma cell lines. Cancer Res.
65:7902–7910. 2005.PubMed/NCBI
|
|
11
|
Reardon DB, Contessa JN, Mikkelsen RB,
Valerie K, Amir C, Dent P and Schmidt-Ullrich RK: Dominant negative
EGFR-CD533 and inhibition of MAPK modify JNK1 activation and
enhance radiation toxicity of human mammary carcinoma cells.
Oncogene. 18:4756–4766. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fokas E, Im JH, Hill S, Yameen S,
Stratford M, Beech J, Hackl W, Maira SM, Bernhard EJ, McKenna WG,
et al: Dual inhibition of the PI3K/mTOR pathway increases tumor
radiosensitivity by normalizing tumor vasculature. Cancer Res.
72:239–248. 2012. View Article : Google Scholar
|
|
13
|
Wang T, Hu YC, Dong S, Fan M, Tamae D,
Ozeki M, Gao Q, Gius D and Li JJ: Co-activation of ERK, NF-kappaB,
and GADD45beta in response to ionizing radiation. J Biol Chem.
280:12593–12601. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuo WT, Ho YJ, Kuo SM, Lin FH, Tsai FJ,
Chen YS, Dong GC and Yao CH: Induction of the mitochondria
apoptosis pathway by phytohemagglutinin erythroagglutinating in
human lung cancer cells. Ann Surg Oncol. 18:848–856. 2011.
View Article : Google Scholar
|
|
15
|
Miean KH and Mohamed S: Flavonoid
(myricetin, quercetin, kaempferol, luteolin, and apigenin) content
of edible tropical plants. J Agric Food Chem. 49:3106–3112. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Agarwal OP and Nagaratnam A:
Radioprotective property of flavonoids in mice. Toxicon.
19:201–204. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park JS, Rho HS, Kim DH and Chang IS:
Enzymatic preparation of kaempferol from green tea seed and its
antioxidant activity. J Agric Food Chem. 54:2951–2956. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li W, Du B, Wang T, Wang S and Zhang J:
Kaempferol induces apoptosis in human HCT116 colon cancer cells via
the Ataxia-Telangiectasia Mutated-p53 pathway with the involvement
of p53 upregulated modulator of apoptosis. Chem Biol Interact.
177:121–127. 2009. View Article : Google Scholar
|
|
19
|
Luo H, Rankin GO, Liu L, Daddysman MK,
Jiang BH and Chen YC: Kaempferol inhibits angiogenesis and VEGF
expression through both HIF dependent and independent pathways in
human ovarian cancer cells. Nutr Cancer. 61:554–563. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
DuPont MS, Day AJ, Bennett RN, Mellon FA
and Kroon PA: Absorption of kaempferol from endive, a source of
kaempferol-3-glucuronide, in humans. Eur J Clin Nutr. 58:947–954.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nöthlings U, Murphy SP, Wilkens LR,
Henderson BE and Kolonel LN: Flavonols and pancreatic cancer risk:
The multiethnic cohort study. Am J Epidemiol. 166:924–931. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leung HW, Lin CJ, Hour MJ, Yang WH, Wang
MY and Lee HZ: Kaempferol induces apoptosis in human lung non-small
carcinoma cells accompanied by an induction of antioxidant enzymes.
Food Chem Toxicol. 45:2005–2013. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jeong JC, Kim MS, Kim TH and Kim YK:
Kaempferol induces cell death through ERK and Akt-dependent
down-regulation of XIAP and survivin in human glioma cells.
Neurochem Res. 34:991–1001. 2009. View Article : Google Scholar
|
|
24
|
Ackland ML, van de Waarsenburg S and Jones
R: Synergistic antiproliferative action of the flavonols quercetin
and kaempferol in cultured human cancer cell lines. In Vivo.
19:69–76. 2005.PubMed/NCBI
|
|
25
|
Kowalski J, Samojedny A, Paul M, Pietsz G
and Wilczok T: Effect of kaempferol on the production and gene
expression of monocyte chemoattractant protein-1 in J774.2
macrophages. Pharmacol Rep. 57:107–112. 2005.PubMed/NCBI
|
|
26
|
Sotibrán AN, Ordaz-Téllez MG and
Rodríguez-Arnaiz R: Flavonoids and oxidative stress in Drosophila
melanogaster. Mutat Res. 726:60–65. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moon SS, Rahman MA, Manir MM and Jamal
Ahamed VS: Kaempferol glycosides and cardenolide glycosides,
cytotoxic constituents from the seeds of Draba nemorosa
(Brassicaceae). Arch Pharm Res. 33:1169–1173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu X, Xie H, Hao J, Jiang Y and Wei X:
Flavonoid glycosides from the seeds of Litchi chinensis. J Agric
Food Chem. 59:1205–1209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fletcher JI, Meusburger S, Hawkins CJ,
Riglar DT, Lee EF, Fairlie WD, Huang DC and Adams JM: Apoptosis is
triggered when prosurvival Bcl-2 proteins cannot restrain Bax. Proc
Natl Acad Sci USA. 105:18081–18087. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nguyen TT, Tran E, Ong CK, Lee SK, Do PT,
Huynh TT, Nguyen TH, Lee JJ, Tan Y, Ong CS, et al:
Kaempferol-induced growth inhibition and apoptosis in A549 lung
cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol.
197:110–121. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pawlik TM and Keyomarsi K: Role of cell
cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol
Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Franken NA, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar
|
